I am reposting important information on this thread, since posters were hijacking my old thread with complaints that had nothing to do with good information on TF. Here it is:
Treating Chronically Ill Patients with Transfer Factor: An Interview with Dr. R, M.D. (excerpt)
Since 1998, Dr. R has been using Transfer Factor to treat her chronically ill patients, and has experienced considerable success in diminishing symptoms and achieving overall health improvements among those patients. In this exclusive interview, Dr. Ryser discusses her experience with Transfer Factor as an effective treatment for chronic illness.
Dr. R: The diagnosis of a patient is of utmost importance. I perform a series of genetic testing with PCR (Polymer Chain Reaction) that tells me the specific bacteria or virus(es) a patient has. Transfer Factor helps with viral, bacterial, and fungal infections as well as parasites, and supports the immune system while treating the problems a patient has. Regarding what formulas of Transfer Factor I use for different patients, I use the plain Transfer Factor as a general prevention treatment, especially for infections and allergies and for patients with Epstein-Barr, Chronic Fatigue Syndrome.
Q: How much Transfer Factor do you typically recommend, and for what kind of patient?
Dr. R: For chronically ill patients, including those with chronic sinusitis, and multiple allergies, I recommend six capsules a day, and depending on the severity of their symptoms, I might recommend up to twelve capsules a day. For children ages 7-12 or 13, depending on weight, I will recommend two capsules a day, to be taken at bedtime.
When a patient is beginning to get sick and is coming down with a fever, I will have them take two capsules every 2-3 hours, for 24 hours, and that usually knocks the virus "off its socks," so to speak. This dosage of Transfer Factor can nip a fever in the bud, by supporting the immune system's natural killer cells.
I also treat fibromyalgia patients with Transfer Factor. I believe that fibromyalgia is most commonly caused by infections, including bacteria, yeast, and parasites. For chronically ill patients dealing with multiple infections, including CNS (Central Nervous System) infections and gastrointestinal infections, I recommend several different Transfer Factor formulas, to be taken together.
Q: How long does it usually take for a patient to experience positive results once they start taking Transfer Factor?
Dr. R: My patients usually start to feel better within 3-6 months of beginning treatment with Transfer Factor. Dramatic results usually manifest in about one year, but we really begin to see positive changes in 5-6 months. It typically takes about a year of Transfer Factor treatment to really turn a patient around. I am specifically referring to chronically ill patients who have an average of 2-7 chronic infections that require treatment. The body's cells regenerate every six months, and you need to give the body a chance to generate healthy cells before dramatic improvements in a patient's overall health can emerge.
Q: What, if any, are the side effects or possible negative reactions that can occur with Transfer Factor therapy?
Dr. R: The initial reactions to Transfer Factor a patient will experience are similar to a vaccination - but without, of course, exposure to the pathogen. The initial reaction typically includes flu-like symptoms, proportionate to the severity of a patient's illness. These flu-like symptoms go away, but they prove that the immune system has been activated, and that it is working to suppress the body's infections.
Regarding the safety of Transfer Factor, I have never had a problem with negative side effects or adverse reactions. However, I am very cautious. I perform careful evaluations of a patient's immune system. I check for viral leukemia, and so forth. I am very careful with cancer and autoimmune patients, with whom you must be cautious with regard to stimulating immune cells - this is particularly the case with Hodgkins Disease and Non-Hodgkins Lymphoma patients.
Q: What have you found to be the most positive benefits of Transfer Factor for your Chronic Fatigue Syndrome patients - what are the best results you have seen?
Dr. R: The patient stops getting sick, and they don't have any more infections. Their cognitive thinking clears up; no more brain fog. Their energy comes back; they can start doing more, and they can start walking and exercising again. They don't suffer relapses. However, when a patient is doing well and they make the personal decision to stop taking Transfer Factor, I have seen relapses. I strongly recommend that a patient takes Transfer Factor for life - that is, it is a lifetime commitment for my chronically ill patients.
[ 02-27-2011, 06:29 PM: Message edited by: Lymetoo ]
Posted by oxygenbabe (Member # 5831) on :
Further to the letter by H.H. Fudenberg appearing in The Scientist of Feb. 17, 1997 [page 13], we would like to point out that, although we agree with his overall contention regarding the beneficial effects of transfer factor even on advanced-stage AIDS patients, our polymerase chain reaction (PCR) data, albeit limited, do not confirm his equally limited observations, suggesting a dramatic drop in the PCR counts. In our experience, only one out of three patients showed an important decrease in PCR counts following transfer factor administration.
Nevertheless and notwithstanding the aforementioned results, most patients who received HIV-specific transfer factor over long periods have shown arrest of disease progression with clinical and/or laboratory improvement.
Furthermore, preliminary studies investigating the serum cytokines in patients receiving transfer factor treatment indicate that the latter activates the Th1 secretion pattern, which has a prognostic value (E. Raise et al., Biotherapy, 9[1-3]:49-54, 1996).
Thus, evidence obtained by our group, as well as by Fudenberg and others (A.A. Gottlieb et al., Biotherapy, 9[1-3]:27-31, 1996), suggests that transfer factor has a beneficial effect on HIV-infected patients, as has proved to be the case in other viral infections. As a matter of fact, the literature abounds with reports confirming the extraordinary efficacy of specific transfer factor, be it for subacute viral infections (such as cytomegalovirus and herpes simplex virus) or chronic, secondary manifestations of viral diseases (hepatitis B, Burkitt's lymphoma, nasopharyngeal carcinoma).
The HIV infection can, in some cases, be controlled by the patient's immune system. Cytotoxic T lymphocytes play a key role in this effect (S. Rowland-Jones et al., Nature Medicine, 1[1]:59-64, 1995). Since one of the postulated activities of transfer factor is the increase in the cytotoxic T lymphocytes recognizing cells displaying "foreign" antigens, be they viral or tumor-associated, and proceeding with their destruction, it is plausible to speculate that it can also generate HIV-specific cytotoxic lymphocytes and thus contribute to arresting the progression of the syndrome.
However, if these observations and speculations had even the slightest probability of being confirmed, considering what is at stake, one should be already asking the "obvious" question: Why, after two decades of prominence, has transfer factor sunk into limbo?
It is true that its molecular structure has not yet been elucidated, but hundreds of papers have been published on this moiety, and the clinical results achieved so far have not been challenged. A recent example of striking clinical efficacy is the work of T. Fujisawa and Y. Yamaguchi at the Chiba University School of Medicine, Japan (T. Fujisawa, Y. Yamaguchi, Cancer, 78[9]: 1892-8, 1996).
In an interesting review of the work of Sigmund Freud, John Horgan (Scientific American, 275[6]:106-11, December 1996) refers to University of Pennsylvania psychologist Lester B. Luborsky's "allegiance effect," which can be redefined as "the tendency of researchers to find evidence favoring the ideas they cherish and ignore evidence favoring the ideas they don't." This has certainly played an important role in the overt or implicit rejection of transfer factor, resulting in the curtailing of funding for further fundamental research into the subject.
Be that as it may, a second question also arises: cui bono? Who is the principal beneficiary of such attitudes? Pharmaceutical companies, commercializing profitably on sometimes highly toxic drugs, are the first to benefit from transfer factor's oblivion, since the latter could be offered at a fraction of the price of the former. And to the "cui malo" question, the obvious answer is "the patient."
Dimitri Viza Laboratoire d'Immunobiologie Faculty de Medicine des Saints-Peres Paris, France
Giancarlo Pizza Immunotherapy Unit First Division of Urology Malpighi Hospital Bologna, Italy
Posted by oxygenbabe (Member # 5831) on :
I'm really feeling this TF--and it is general--obviously just made from colostrum. The flulike part is irritating---I'm achy, pains in my muscles that are sort of strange, irritable, and I crashed out in a long nap yesterday----I'm having more inflammation, too...but I know it is killing stuff from my improved symptoms.
I'm going to research this further. The reason I never did before was because 4Life had no effect on me at all so I thought it was all a scam.
I think many of us have defects in cell mediated immunity for certain bugs, either lyme, or because of lyme. This could help. However it might need to be made in labs for the specific person and their specific infections.
Posted by oxygenbabe (Member # 5831) on :
Note: I am taking Oramune.
I will follow up by contacting some of the researchers in Mexico and Italy.
Posted by blinkie (Member # 14470) on :
I was taking one and had improvement in some symptoms, but I could not afford to continue to take it at $130 a bottle and that was without shipping costs.
Posted by oxygenbabe (Member # 5831) on :
That is Chisolm I believe. This is not specific, it is general TF and is much cheaper.
Posted by btmb03 (Member # 18394) on :
![[Smile]](smile.gif)